Objective: Paradoxical vocal fold motion (PVFM) is responsive to behavioral therapy, often resulting in a remission of symptoms, but little is known about whether treatment is beneficial with regard to PVFM-associated psychological symptoms or functional limitations. The goal of the study was to identify patient perceptions of the impact of treatment for PVFM and characteristics associated with treatment outcomes. Methods: A survey was conducted of all adults who had received at least 1 session of treatment for PVFM in our outpatient clinic over a 2-year period. Results: The 39 participants ranged in age from 18 to 82 and had received a median of 3 treatment sessions. At a median follow-up of 10 months following treatment, respondents reported improvements in a wide range of areas, including sports and leisure, daily activities, and social participation. The majority reported improvements in feelings of anxiety, helplessness, and control. Poorer outcomes were associated with more severe voice symptoms, fewer treatment sessions, and needing oral steroids for asthma control. Conclusion: There was a reduction in a wide range of activity limitations after treatment. Feelings of control were strongly associated with positive outcomes. The therapy appeared to be equally effective for adults with exercise-induced and environmental variants of PVFM.

Keywords:
Vocal cord dysfunction, Paradoxical vocal fold motion, Speech pathology, Self-efficacy, Treatment outcomes, Respiration, Dysphonia, Physical activity, Psychological function
1.
Murry T, Sapienza C: The role of voice therapy in the management of paradoxical vocal fold motion, chronic cough, and laryngospasm. Otolaryngol Clin North Am 2009; 43: 73–83.
2.
Dinulos J, Karas D, Carey J, DelBeccaro M: Paradoxical vocal cord motion presenting as acute stridor. Ann Emerg Med 1997; 29: 815–817.
3.
Ferris R, Eisele D, Tunkel D: Functional laryngeal dyskinesia in children and adults. Laryngoscope 1998; 108: 1520–1523.
4.
Kuppersmith R, Rosen D, Wiatrack B: Functional stridor in adolescents. J Adolesc Health 1993; 14: 166–171.
5.
La Rouere M, Koopman C: Non-organic stridor in children. Int J Pediatr Otorhinolaryngol 1987; 14: 73–77.
6.
Powell D, Karanfilov B, Beechler K, Treole K, Trudeau M, Forrest L: Paradoxical vocal cord dysfunction in juveniles. Arch Otolaryngol Head Neck Surg 2000; 126: 29–34.
7.
Patel RR, Venediktov R, Schooling T, Wang B: Evidence-based systematic review: effects of Speech-Language Pathology treatment for individuals with paradoxical vocal fold motion. Am J Speech Lang Pathol 2015; 24: 566–584.
8.
Doshi DR, Weinberger MM: Long-term outcome of vocal cord dysfunction. Ann Allergy 2004; 96: 794–799.
9.
Sullivan MD, Heywood BM, Beukelman DR: A treatment for vocal cord dysfunction in female athletes: an outcome study. Laryngoscope 2001; 111: 1751–1755.
10.
Rameau A, Foltz RS, Wagner K, Zur KB: Multidisciplinary approach to vocal cord dysfunction diagnosis and treatment in one session: a single institutional outcome study. Int J Pediatr Otorhinolaryngol 2011; 76: 31–35.
11.
Hoyte FCL: Vocal cord dysfunction. Immunol Allergy Clin North Am 2013; 33: 1–22.
12.
Fischer DH, Stewart AL, Bloch DA, Lorig K, Laurent D, Holman H: Capturing the patient’s view of change as a clinical outcome measure. JAMA 1999; 282: 157–1162.
13.
Mathers-Schmidt BA: Paradoxical vocal fold motion: a tutorial on a complex disorder and the speech-language pathologist’s role. Am J Speech Lang Pathol 2001; 10: 111–125.
14.
Reitz JR, Gorman SG, Kegyes J: Behavioral management of paradoxical vocal fold motion. Am Speech Lang Hear Assoc SIG 3 Perspect Voice Voice Disord 2014; 24: 64–70.
15.
Blager F: Vocal cord dysfunction. Am Speech Lang Hear Assoc SIG 3 Perspect Voice Voice Disord 2006; 16: 7–10.
16.
Martin RJ, Blager FB, Gay ML, Wood RP: Paradoxical vocal cord motion in presumed asthmatics. Semin Respir Med 1987; 8: 332–337.
17.
World Health Organization: International Classification of Functioning, Disability and Health. Geneva, World Health Organization, 2001.
18.
Threats TT: Towards an international framework for communication disorders: use of the ICF. J Commun Disord 2006; 39: 251–265.
19.
Maturo S, Hill C, Bunting G, Baliff C, Ramakrishna J, Scirica C, Fracchia S, Donovan A, Hartnick C: Pediatric paradoxical vocal-fold motion: presentation and natural history. Pediatrics 2011; 128:e1443–e1449.
20.
Rameau A, Foltz RS, Wagner K, Zur KB: Multidisciplinary approach to vocal cord dysfunction diagnosis and treatment in one session: a single institutional outcome study. Int J Pediatr Otorhinolaryngol 2012; 76: 31–35.
21.
Dunn NM, Katial RK, Hoyte FCL: Vocal cord dysfunction: a review. Asthma Res Pract 2015; 1: 9.
22.
Christopher KL, Wood RP, Eckert C, Blager FB, Raney RA, Souhrada JF: Vocal-cord dysfunction presenting as asthma. N Engl J Med 1983; 308: 1566–1570.
23.
Ramírez RJ, León I, Rivera LM: Episodic laryngeal dyskinesia: clinical and psychiatric characterization. Chest 1986; 90: 716–721.
24.
Brown TM, Merritt WD, Evans DL: Psychogenic vocal cord dysfunction masquerading as asthma. J Nerv Ment Dis 1988; 176: 308–310.
25.
Freedman MR, Rosenberg SJ, Schmaling KB: Childhood sexual abuse in patients with paradoxical vocal cord dysfunction. J Nerv Ment Dis 1991; 179: 295–298.
26.
Lacy TJ, McManis SE: Psychogenic stridor. Gen Hosp Psychiatry 1994; 16: 213–223.
27.
Newman KB, Mason UG, Schmaling KB: Clinical features of vocal cord dysfunction. Am J Respir Crit Care Med 1995; 152: 1382–1386.
28.
Powell SA, Nguyen CT, Gaziano J, Lewis V, Lockey RF, Padhya TA: Mass psychogenic illness presenting as acute stridor in an adolescent female cohort. Ann Otol Rhinol Laryngol 2007; 116: 525–531.
29.
Newman KB, Dubester SN: Vocal cord dysfunction: masquerader of asthma. Semin Respir Crit Care Med 1994; 15: 161–167.
30.
Perkner JJ, Fennelly KP, Balkissoon R, Bartelson BB, Ruttenber AJ, Wood RP, Newman LS: Irritant-associated vocal cord dysfunction. J Occup Environ Med 1998; 40: 136–143.
31.
Bandura A: Self-efficacy: towards a unifying theory of behavior change. Psychol Rev 1977; 84: 191–215.
32.
Romppel M, Herrmann-Lingen C, Wachter R, Edelmann F, Düngen HD, Pieske B, Grande G: A short form of the General Self-Efficacy Scale (GSE-6): development, psychometric properties and validity in an intercultural non-clinical sample and a sample of patients at risk for heart failure. Psychosoc Med 2013; 10: 1–7.
33.
Chiang T, Marcinow AM, deSilva BW, Ence BN, Lindsey SE, Forrest LA: Exercise-induced paradoxical vocal fold motion disorder. Laryngoscope 2013; 123: 727–731.
34.
Mathers-Schmidt BA, Brilla LR: Inspiratory muscle training in exercise-induced paradoxical vocal fold motion. J Voice 2005; 19: 635–644.
35.
Murry T, Tabaee A, Owczarzak V, Aviv JE: Respiratory retraining therapy and management of laryngopharyngeal reflux in the treatment of patients with cough and paradoxical vocal fold movement disorder. Ann Otol Rhinol Laryngol 2006; 115: 754–758.
36.
Murry T, Branski RC, Yu K, Cukier-Blaj S, Duflo S, Aviv JE: Laryngeal sensory deficits in patients with chronic cough and paradoxical vocal fold movement disorder. Laryngoscope 2010; 120: 1576–1581.
37.
Nacci A, Fattori B, Segnini G, Dallan I, Panicucci E, Rocchi V, Ursino F: Respiratory retraining therapy in long-term treatment of paradoxical vocal fold dysfunction. Folia Phoniatr Logop 2011; 63: 134–141.
38.
Towey MP: Speech therapy telepractice for vocal cord dysfunction (VCD): mainecare (Medicaid) cost savings. Int J Telerehabil 2012; 4: 33.
39.
van Leer E, Connor NP: Patient perceptions of voice therapy adherence. J Voice 2010; 24: 458–469.
40.
Portone C, Johns MM, Hapner ER: A review of patient adherence to the recommendation for voice therapy. J Voice 2008; 22: 192–196.
41.
Vertigan AE, Theodoros DG, Winkworth AL, Gibson PG: A comparison of two approaches to the treatment of chronic cough: perceptual, acoustic, and electroglottographic outcomes. J Voice 2008; 22: 581–589.
42.
Vertigan AE, Theodoros DG, Gibson PG, Winkworth AL: The relationship between chronic cough and paradoxical vocal fold movement: a review of the literature. J Voice 2006; 20: 466–480.
43.
Drake K, Palmer AD: Promoting optimal outcomes in VCD: the role of self-efficacy. Presented at the American Speech-Language Hearing Association Annual Convention, Chicago, IL, 2013.
44.
Smith SL, West RL: The application of self-efficacy principles to audiologic rehabilitation: a tutorial. Am J Audiol 2006; 15: 46–56.
45.
Guyatt GH, Norman GR, Juniper EF, Griffith LE: A critical look at transition ratings. J Clin Epidemiol 2002; 55: 900–908.
46.
Hartley NA, Petty BE, Johnson B, Thibeault SL: Comparative analysis of clinical profile: chronic cough vs paradoxical vocal fold motion. Respir Med 2015; 109: 1516–1520.
47.
Gartner-Schmidt JL, Shembel AC, Zullo TG, Rosen CA: Development and validation of the Dyspnea Index (DI): a severity index for upper airway – related dyspnea. J Voice 2014; 28: 775–782.
48.
Fowler SJ, Thurston A, Chesworth B, Cheng V, Constantinou P, Vyas A, Lillie S, Haines J: The VCDQ: a questionnaire for symptom monitoring in vocal cord dysfunction. Clin Exp Allergy 2015; 45: 1406–1411.
© 2018 S. Karger AG, Basel
2018
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.